Invariant natural killer T cells in patients with common variable immunodeficiency - 02/10/14
![](/templates/common/images/mail.png)
Disclosure of potential conflict of interest: D. Paquin-Proulx received a postdoctoral fellowship from the Canadian Institutes of Health Research. E. G. Kallas has received research support from the National Institute of Allergy and Infectious Diseases. J. K. Sandberg has received research support from the Swedish Research Council (grant no. 2011-3412), the Swedish Cancer Society (grant no. CAN 2011/834), Stockholm County Council, and Karolinska Institutet; has received consultancy fees from the Swedish Research Council; and is employed by Karolinska Institutet. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 134 - N° 4
P. 989-990 - octobre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?